跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BROXOLEX - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
BROXOLEX
Approved
STANDARD
BROXOLEX
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
0e38e1e5a779904b
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
0e38e1e5a779904b
Drug Approval Philippines Name
BROXOLEX
Product Name
BROXOLEX
Registration Number
DRP-6794-03
Brand Name
BROXOLEX
Generic Name
Ambroxol hydrochloride
Dosage Form
Syrup
Dosage Strength
15mg/5mL
Manufacturer
Lloyd Laboratories, Inc.
Trader
EADRIEX PHARMACEUTICALS PHILS., INC.
Distributor
Transcend Phils. Inc.
Issuance Date
24 June 2022
Expiry Date
21 March 2027
Pharmacologic Category
Mucolytic
Classification
Over-The-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
0e38e1e5a779904b
Type
Standard
Back to Philippines FDA Approvals